Artists With 'Invisible' Disabilities Use Tattoos To Talk About Health
“I have chosen a surreal art approach to represent my invisible disability, due to the surreal nature of mental illness,” tattoo artist Lindsay Carter expressed in a statement. Carter’s image ― featured on the right, above ― shows a bird whose head is a cage with a giant eyeball protruding from the dreamlike vision. “As long as I’ve been consciously aware, I’ve been diagnosed with generalized anxiety disorder and major depressive disorder,” she continued. “Severe episodes can happen for no apparent reason and at that point I cannot help nor snap out of the exaggerated feelings. I subjectively illustrate mental illness as being caged within your own mind.” Carter is one of five tattoo artists who make up Ink Visible, a collaborative effort to visualize disabilities that, until now, have remained invisible. Each contributing artist has created their own temporary tattoo design, reflecting experiences with disabilities that exist inside the brain and underneath the skin, giving color and shape to the symptoms and experiences that can’t be seen and often remain misunderstood. Ink Visible is the brainchild of artist Arianna Warner, who has a chronic pain condition called Reflex Sympathetic Dystrophy. Because her RSD prevents her from getting permanent tattoos of her own, Warner had the idea to use temporary tattoos as a vehicle through which to communicate what, for so long, seeme...
CONCLUSIONS: Our findings support the protective effect a normal weight against advanced adenomas. Reduction of BMI value should be pursued in healthy programs. PMID: 32233893 [PubMed - as supplied by publisher]
Conclusion: There is a slightly increasing trend in the occurrence of esophageal perforations. Contemporary treatment is less invasive with similar results. Patients treated in high-volume hospitals have better prognosis. PMID: 32233883 [PubMed - as supplied by publisher]
Publication date: 12 April 2020Source: Nutrition, Metabolism and Cardiovascular Diseases, Volume 30, Issue 4Author(s): Huanhuan Wang, Ying Song, Xiaofang Tang, Jingjing Xu, Ping Jiang, Lin Jiang, Zhan Gao, Jue Chen, Lei Song, Yin Zhang, Xueyan Zhao, Shubin Qiao, Yuejin Yang, Runlin Gao, Bo Xu, Jinqing Yuan, Lijian Gao
Publication date: May 2020Source: Epilepsy &Behavior, Volume 106Author(s): Yanhong Yang, Mengyang Yang, Qianling Shi, Tiancheng Wang, Min Jiang
More than one fifth of patients who are treated for gynecologic malignancies experience financial toxicity, results of a single-center study suggest.
Publication date: Available online 2 April 2020Source: Journal of the Formosan Medical AssociationAuthor(s): Chun-Wei Lee, Shu-Hao Wu, Wen-Chi Chiu, Shih-Tzer Tsai, Tzuo-Yun Lan
Authors: Alcázar-Leyva S, Zapata E, Bernal-Alcántara D, Gorocica P, Alvarado-Vásquez N Abstract Although thiamine pyrophosphate (TPP) is considered a protective agent for endothelial cells, it is still unknown if this is associated with nitric oxide (NO) synthesis. Our aim was to evaluate the synthesis of NO in endothelial cells incubated with TPP and high glucose concentrations. Endothelial cells from the umbilical cord vein from newborns (n = 20), were incubated with 5, 15 or 30 mmol/L glucose, in absence or presence of 0.625 mg/ml of TPP. Our results showed a significant...
Results of a systematic review and meta-analysis support a possible role for osimertinib in the management of non-small-cell lung cancer (NSCLC) patients with intracranial metastatic disease, researchers say.Reuters Health Information
Authors: Montemurro F, Nuzzolese I, Ponzone R Abstract Introduction: The administration of chemotherapy before (neoadjuvant), rather than after surgery (adjuvant) in early breast cancer has been considered an optional strategy for patients with operable breast cancer. We reviewed this concept considering recent results in the field.Areas covered: Herein, the authors cover neoadjuvant chemotherapy with or without biologics in triple-negative and HER2-positive operable breast cancer with a focus on rates of complete pathological remission (pCR) in the breast and axilla. The impact of the CREATE X and KATERINE randomi...
In this study, we aimed to analyze the expression of glycan-processing genes in DRG neurons from a leptin-deficient genetic mouse model of diabetes (db/db). Transcriptomic analysis revealed that several glycan-processing genes encoding for glycosyltransferases and sialic acid-modifying enzymes were upregulated in diabetic conditions. Functional analysis of these enzymes on recombinant Cav3.2 revealed an unexpected loss-of-function of the channel. Collectively, our data indicate that diabetes is associated with an alteration of the glycosylation machinery in DRG neurons. However, individual action of these enzymes when test...
More News: ADHD | Anxiety | Autism | Back Pain | Bipolar | Brain | Brain Cancers | Cancer | Cancer & Oncology | Chronic Pain | Complex Regional Pain Syndrome | Depression | Diabetes | Disability | Endocrinology | Generalized Anxiety Disorder (GAD) | Health | Mania | Medical Ethics | Men | Neurology | Pain | Post Traumatic Stress Disorder | Reflex Sympathetic Dystrophy | Schizophrenia | Skin | Sports Medicine | Websites